Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0R0XY
|
|||
Former ID |
DNC010882
|
|||
Drug Name |
C[YYDEGLEE]-NH2
|
|||
Synonyms |
CHEMBL389147; c[YYDEGLEE]-NH2; BDBM50223446
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
Structure |
Download2D MOL |
|||
Formula |
C45H59N9O17
|
|||
Canonical SMILES |
CC(C)CC1C(=O)NC(C(=O)NC(CCC(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NCC(=O)N1)CCC(=O)O)CC(=O)O)CC2=CC=C(C=C2)O)CC3=CC=C(C=C3)O)C(=O)N)CCC(=O)O
|
|||
InChI |
1S/C45H59N9O17/c1-22(2)17-30-42(68)52-29(13-16-37(61)62)41(67)50-27(39(46)65)11-14-34(57)48-31(18-23-3-7-25(55)8-4-23)43(69)53-32(19-24-5-9-26(56)10-6-24)44(70)54-33(20-38(63)64)45(71)51-28(12-15-36(59)60)40(66)47-21-35(58)49-30/h3-10,22,27-33,55-56H,11-21H2,1-2H3,(H2,46,65)(H,47,66)(H,48,57)(H,49,58)(H,50,67)(H,51,71)(H,52,68)(H,53,69)(H,54,70)(H,59,60)(H,61,62)(H,63,64)/t27-,28-,29-,30-,31-,32-,33-/m0/s1
|
|||
InChIKey |
FRCBDVBWQMWQOW-MRNVWEPHSA-N
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | VEGFR1 messenger RNA (VEGFR1 mRNA) | Target Info | Inhibitor | [1] |
KEGG Pathway | Ras signaling pathway | |||
Rap1 signaling pathway | ||||
Cytokine-cytokine receptor interaction | ||||
HIF-1 signaling pathway | ||||
Endocytosis | ||||
PI3K-Akt signaling pathway | ||||
Focal adhesion | ||||
Transcriptional misregulation in cancer | ||||
Rheumatoid arthritis | ||||
Pathway Interaction Database | Glypican 1 network | |||
HIF-2-alpha transcription factor network | ||||
S1P3 pathway | ||||
VEGF and VEGFR signaling network | ||||
VEGFR1 specific signals | ||||
Signaling events mediated by VEGFR1 and VEGFR2 | ||||
Reactome | Neurophilin interactions with VEGF and VEGFR | |||
VEGF binds to VEGFR leading to receptor dimerization | ||||
WikiPathways | Focal Adhesion | |||
Signaling by VEGF | ||||
Angiogenesis |
References | Top | |||
---|---|---|---|---|
REF 1 | Biochemical and structural analysis of the binding determinants of a vascular endothelial growth factor receptor peptidic antagonist. J Med Chem. 2010 Jun 10;53(11):4428-40. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.